Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anantha Shekhar

Showing results (131-140 of 152) with videos related to

Pageof 16
Sort By:
Alcoholism, Clinical and Experimental Research|March 12, 2014
Alcohol-preferring rats show decreased corticotropin-releasing hormone-2 receptor expression and differences in HPA activation compared to alcohol-nonpreferring ratsWeidong Yong, John Paul Spence, Robert Eskay, et al.
Pharmacology, Biochemistry, and Behavior|October 18, 2015
Pharmacological depletion of serotonin in the basolateral amygdala complex reduces anxiety and disrupts fear conditioningPhilip L Johnson, Andrei Molosh, Stephanie D Fitz, et al.
Archives of Autoimmune Diseases|January 29, 2021
Utilization of electronic health records for the assessment of adiponectin receptor autoantibodies during the progression of cardio-metabolic comorbiditiesMichael J Pugia, Meeta Pradhan, Rong Qi, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 13, 2020
The Rewarding and Anxiolytic Properties of Ethanol within the Central Nucleus of the Amygdala: Mediated by Genetic Background and NociceptinChristopher P Knight, Sheketha R Hauser, R Aaron Waeiss, et al.
Critical Care Medicine|November 27, 2019
Biomarkers of Delirium Duration and Delirium Severity in the ICUBabar A Khan, Anthony J Perkins, Nagendra K Prasad, et al.
Oncotarget|January 15, 2015
Ferroxitosis: a cell death from modulation of oxidative phosphorylation and PKM2-dependent glycolysis in melanomaAlexander J Lakhter, James Hamilton, Pierre C Dagher, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2015
A selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effectsPascal Bonaventure, Sujin Yun, Philip L Johnson, et al.
International Journal of General Medicine|December 11, 2013
S100 calcium binding protein B as a biomarker of delirium duration in the intensive care unit - an exploratory analysisBabar A Khan, Mark O Farber, Noll Campbell, et al.
The Journal of Biological Chemistry|January 19, 2020
The small molecule GAT1508 activates brain-specific GIRK1/2 channel heteromers and facilitates conditioned fear extinction in rodentsYu Xu, Lucas Cantwell, Andrei I Molosh, et al.
The Journal of Clinical Psychiatry|November 19, 2008
Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind studyMauricio Tohen, Eduard Vieta, Guy M Goodwin, et al.
Pageof 16

Showing results (131-140 of 152) with videos related to

Sort By:
Pageof 16
Alcoholism, Clinical and Experimental Research|March 12, 2014
Alcohol-preferring rats show decreased corticotropin-releasing hormone-2 receptor expression and differences in HPA activation compared to alcohol-nonpreferring ratsWeidong Yong, John Paul Spence, Robert Eskay, et al.
Pharmacology, Biochemistry, and Behavior|October 18, 2015
Pharmacological depletion of serotonin in the basolateral amygdala complex reduces anxiety and disrupts fear conditioningPhilip L Johnson, Andrei Molosh, Stephanie D Fitz, et al.
Archives of Autoimmune Diseases|January 29, 2021
Utilization of electronic health records for the assessment of adiponectin receptor autoantibodies during the progression of cardio-metabolic comorbiditiesMichael J Pugia, Meeta Pradhan, Rong Qi, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 13, 2020
The Rewarding and Anxiolytic Properties of Ethanol within the Central Nucleus of the Amygdala: Mediated by Genetic Background and NociceptinChristopher P Knight, Sheketha R Hauser, R Aaron Waeiss, et al.
Critical Care Medicine|November 27, 2019
Biomarkers of Delirium Duration and Delirium Severity in the ICUBabar A Khan, Anthony J Perkins, Nagendra K Prasad, et al.
Oncotarget|January 15, 2015
Ferroxitosis: a cell death from modulation of oxidative phosphorylation and PKM2-dependent glycolysis in melanomaAlexander J Lakhter, James Hamilton, Pierre C Dagher, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2015
A selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effectsPascal Bonaventure, Sujin Yun, Philip L Johnson, et al.
International Journal of General Medicine|December 11, 2013
S100 calcium binding protein B as a biomarker of delirium duration in the intensive care unit - an exploratory analysisBabar A Khan, Mark O Farber, Noll Campbell, et al.
The Journal of Biological Chemistry|January 19, 2020
The small molecule GAT1508 activates brain-specific GIRK1/2 channel heteromers and facilitates conditioned fear extinction in rodentsYu Xu, Lucas Cantwell, Andrei I Molosh, et al.
The Journal of Clinical Psychiatry|November 19, 2008
Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind studyMauricio Tohen, Eduard Vieta, Guy M Goodwin, et al.
Pageof 16